10
Phase 2–4 trials
Lipid & Lp(a) therapies · Live ClinicalTrials.gov data
Pelacarsen clinical trial pipeline
ClinicalTrials.gov lists 10 phase 2–4 trials for pelacarsen, 4 of them actively recruiting. The next phase 3 primary completion among them is expected Feb 2028. Refreshed daily — add up to four competitors to compare pipelines side by side.
8
Phase 3 trials
4
Actively recruiting
Feb 2028
Next phase 3 primary completion
16,504
Participants across trials
Novartis Pharmaceuticals
Lead sponsor by trial count
pelacarsen (10)7 active2017–2032
pelacarsen
'17
'19
'21
'23
'25
'27
'29
'31
pelacarsen
Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular DiseaseP2
Lp(a)HORIZONP3
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in GermanyP3
OLEP3
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisP2
Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDP3
ADD-VANTAGEP3
Pelacarsen Roll-over Extension ProgramP3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)P3
Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARLP3
Upcoming readouts
6 ahead · pelacarsen
Select a trial to load its full ClinicalTrials.gov record.
Key pelacarsen trials
Top 10 of the 10 registered phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06813911 | ADD-VANTAGE — Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and… | Phase 3 | Recruiting | Feb 2028 |
| NCT07517263 | An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and T… | Phase 3 | Recruiting | Jan 2030 |
| NCT06875973 | Pelacarsen Roll-over Extension Program | Phase 3 | Recruiting | Dec 2030 |
| NCT04023552 | Lp(a)HORIZON — Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Pa… | Phase 3 | Active, not recruiting | Jun 2026 |
| NCT05900141 | OLE — An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) | Phase 3 | Active, not recruiting | Aug 2028 |
| NCT07625306 | Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NS… | Phase 3 | Not yet recruiting | Dec 2028 |
| NCT05305664 | A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of We… | Phase 3 | Completed | Jan 2025 |
| NCT06267560 | Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevat… | Phase 3 | Completed | Mar 2026 |
| NCT05646381 | A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progressio… | Phase 2 | Recruiting | Mar 2030 |
| NCT03070782 | Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascula… | Phase 2 | Completed | Jul 2018 |
Related drug pipelines
FAQ
- How many clinical trials are running for pelacarsen?
- ClinicalTrials.gov currently lists 10 phase 2–4 pelacarsen trials: 2 phase 2, 8 phase 3, and 0 phase 4. 4 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare pelacarsen against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.